Fuan Pharmaceutical (300194.SZ) subsidiary receives the drug registration certificate for injectable ceftazidime avibactam.

Zhitong Caijing APP News, Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co., Ltd., recently received the drug registration certificate for Cefoperazone Avibactam for injection issued by the National Medical Products Administration. Cefoperazone Avibactam for injection is indicated for the treatment of complicated intra-abdominal infections; hospital-acquired pneumonia and ventilator-associated pneumonia; and infections caused by gram-negative bacteria susceptible to this product in adult patients with limited options for treatment and pediatric patients from birth.